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AbsTrACT
background The absence of any agreed- upon tendon 
health- related domains hampers advances in clinical 
tendinopathy research. This void means that researchers 
report a very wide range of outcome measures 
inconsistently. As a result, substantial synthesis/meta- 
analysis of tendon research findings is almost futile 
despite researchers publishing busily. We aimed to 
determine options for, and then define, core health- 
related domains for tendinopathy.
Methods We conducted a Delphi study of healthcare 
professionals (HCP) and patients in a three- stage 
process. In stage 1, we extracted candidate domains 
from clinical trial reports and developed an online survey. 
Survey items took the form: ’The ’candidate domain’ 
is important enough to be included as a core health- 
related domain of tendinopathy’; response options were: 
agree, disagree, or unsure. In stage 2, we administered 
the online survey and reported the findings. Stage 3 
consisted of discussions of the findings of the survey 
at the ICON (International Scientific Tendinopathy 
Symposium Consensus) meeting. We set 70% participant 
agreement as the level required for a domain to be 
considered ’core’; similarly, 70% agreement was required 
for a domain to be relegated to ’not core’ (see Results 
next).
results Twenty- eight HCP (92% of whom had >10 
years of tendinopathy experience, 71% consulted >10 
cases per month) and 32 patients completed the online 
survey. Fifteen HCP and two patients attended the 
consensus meeting. Of an original set of 24 candidate 
domains, the ICON group deemed nine domains to be 
core. These were: (1) patient rating of condition, (2) 
participation in life activities (day to day, work, sport), (3) 
pain on activity/loading, (4) function, (5) psychological 
factors, (6) physical function capacity, (7) disability, (8) 
quality of life and (9) pain over a specified time. Two of 
these (2, 6) were an amalgamation of five candidate 
domains. We agreed that seven other candidate domains 
were not core domains: range of motion, pain on 
clinician applied test, clinical examination, palpation, 
drop out, sensory modality pain and pain without 
other specification. We were undecided on the other 
five candidate domains of physical activity, structure, 
medication use, adverse effects and economic impact.
Conclusion Nine core domains for tendon research 
should guide reporting of outcomes in clinical trials. Further 
research should determine the best outcome measures for 
each specific tendinopathy (ie, core outcome sets).
InTroduCTIon
If we review the past two decades of tendinop-
athy research, it appears that progress in patient 
outcomes is on a plateau.1 2 One factor that may 
have limited progress is that few tendon studies 
have lent themselves to meta- analysis,3 4 so that the 
clinical and research community has not agreed on 
treatment guidelines for the major tendinopathies. 
A specific barrier to meta- analysis of tendon treat-
ment studies is that the original research studies 
report many disparate outcome measures,3–5 most 
of which have not been validated.6 A prerequisite 
for authors to be able to synthesise and meta- analyse 
research findings from different studies system-
atically is for numerous studies to contain similar 
outcome measures. It can help to guide a field of 
clinical research if core outcomes are proactively 
defined and established as a core outcome set.7
Before a community of researchers adopt core 
outcomes widely, the key actors usually first agree- 
upon core domains. Let us explain the important 
difference and their logical sequence. The ultimate 
goal, a core outcome set, refers to validated outcome 
measures that capture core health- related domains 
specific to a condition that have been agreed- upon 
by patients and healthcare professionals (HCP: clini-
cians and researchers). A very successful example 
comes from the Outcome Measures in Rheuma-
tology (OMERACT) initiative8 where researchers 
and patients developed a conceptual framework 
to identify core domains (first) before defining a 
core outcome set.9 This approach guided our study 
and this consensus statement is limited to the first 
part—determining core domains. The next phase 
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for tendon researchers, developing core outcome measures for 
specific tendinopathies, is planned for 2020 and beyond.
We aimed to establish (health- related) core domains for tend-
inopathy. We used a three- stage process: (1) a literature review 
of clinical trials on tendinopathy, which informed the items 
(candidate domains) to be included in an online survey, (2) an 
online survey of HCP and patients seeking their opinion on 
key domains, and finally (3) a consensus meeting of HCP and 
patients to make decisions on what should be the core domains.
MeThods
We conducted a consensus process involving HCP and patients, 
which commenced with some of us generating candidate domains 
from a review of literature (stage 1, June 2018). These candi-
date domains were then considered for their importance as core 
health- related domains in tendinopathy, first by online survey 
(stage 2, August 2018) and then at an in- person meeting at the 
2018 International Scientific Tendinopathy Symposium (ISTS, 
Groningen, the Netherlands) (stage 3, September 2018). The 
consensus process described here was one of three separate proj-
ects discussed at the ISTS consensus meeting; the other two dealt 
with terminology10 and reporting of participant characteristics.11
Participants
To achieve a representative group of tendinopathy experts, we 
selected the HCP cohort based on their track record primarily, 
with consideration for a balance of different professional disci-
plines, sex, likely attendance at the ISTS consensus meeting and 
geographical distribution. The aim was to have an online cohort 
of approximately 30 participating HCP, with as many of these to 
attend the dedicated consensus meeting the day before the ISTS 
symposium. This number of participants is based on previous 
Delphi studies in similar areas and regarded as an optimal sample 
size to answer our research question.12 All participants signed an 
agreement (online supplementary appendix A) when they accepted 
the invitation to participate. This stipulated the expectations of 
participation, as well as the rules for the consensus process and 
authorship of publications.
We aimed to recruit at least 30 patients. For this, we used two 
research databases of patients with verified upper and lower limb 
tendinopathies on clinical or clinical plus imaging examination in 
Brisbane and Melbourne (Australia). The patients on these data-
bases were invited to complete the online survey. The head of the 
local scientific committee of ISTS at Groningen (JZ) asked two 
patients from their clinical research unit to participate during the 
consensus meeting. These patients were proficient in English so 
they could participate in the survey and engage in the English- 
language meeting.
Informed consent was obtained from all participants.
Procedure stage 1—identifying outcome measures and formulating 
a candidate domain list
The candidate domain list was formed by first undertaking 
a scoping review of published clinical trials in tendinopathy 
between 2008 and 2018. This generated 122 relevant papers 
and one investigator (BV) extracted all outcome measures 
reported in those trials. For rigour, a research assistant inde-
pendently extracted outcomes from a random selection of 20% 
of those papers, which were then crosschecked. The aim was to 
generate the broadest possible capture of outcomes from which 
the survey’s candidate domain list was derived.
To move from outcome measures to domains, investigators JZ, 
SMcA, EKR, AS, BV and AW then constructed a list of potential 
domains that would make up the items of the survey. The aim 
was not to consolidate domains at this stage, but to ensure that 
all outcomes were aligned to a potential domain. To guide us, 
we used the International Classification of Functioning (ICF) 
aligned (https://www. who. int/ classifications/ icf/ en/) OMERACT 
core areas of (1) life impact, (2) pathophysiological manifesta-
tions, (3) resource use and (4) death.9
Procedure stage 2—online survey relating to candidate domains
The candidate domains formed the basis of the online survey 
(online supplementary appendix B). Each candidate domain was 
included as a separate survey question taking the form ‘Is the 
domain “candidate domain” important enough to be included in a 
Core Domain Set for Tendinopathy?’ and included examples of the 
outcome measures that were aligned with the candidate domain 
(online supplementary appendix B and Results for alignment).
Survey respondents had three options in response to each 
question: agree (yes), disagree (no) or unsure. The consensus 
committee (JZ, EKR, AS, AW, SMcA, BV) made an a- priori crite-
rion decision that ≥70% of ‘agree’ responses would elevate a 
candidate domain into the ‘core’ and ≥70% of disagree responses 
would relegate the candidate domain to not being considered as 
a core domain.9 13 The candidate domains that fell between these 
limits of agreement (‘unsure’) were the focus of our discussion 
session at the ISTS consensus meeting.
Procedure stage 3—ISTS 2018 consensus meeting
The results from the online survey were collated (online supple-
mentary appendix C) and circulated to all HCP and the two 
patients 10 days prior to the consensus meeting. At the consensus 
meeting, the candidate domains that had been voted as ‘unsure’ 
(ie, not already included or excluded from the domain set) were 
discussed in turn. HCP and patients (ie, the group members) then 
voted as to whether they ‘agreed’ or ‘disagreed’ with each candidate 
being a core domain (forced choice). As with the online survey, a 
domain had to earn ≥70% of the delegates’ votes for either ‘agree’ 
or ‘disagree’ to be classified into either of those categories.
resulTs
Participants—hCP
Thirty HCP were invited to participate in the overall Delphi process 
(potentially all three stages) and 28 responded to the online survey 
(one did not respond within the timeframe and one withdrew after 
agreeing to participate due to personal reasons, unrelated to the 
survey). Most of the cohort were clinician–researchers with at least 
11 years working in the field and most (68%) had suffered from 
tendinopathy personally at some point.
Of these 28 individuals, 15 (54%) attended the ISTS consensus 
meeting in Groningen on the 26 September 2018 (table 1). The 
meeting group was representative of the online survey group in 
terms of sex, cases of tendinopathy consulted per month, years 
of clinical experience in the field of tendinopathy and having a 
tendinopathy. There were proportionally more physiotherapists 
than medical professionals at the meeting. No surgeons attended 
the consensus meeting (table 1).
Participants–patient partners
All 219 patients registered on the research centres’ databases 
were sent an email inviting them to participate in the survey, 
with 56 (26%) clicking on the survey link, of which 32 (57%) 
then provided consent and completed the survey. A 55- year- old 
woman with Achilles tendinopathy not related to a specific sports 
participation and a 30- year- old man who was a former elite 
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Table 1 Characteristics of the participants completing the online survey and attending the consensus meeting
Characteristic
survey Meeting
healthcare professionals Patients healthcare professionals Patients
n 28 31 15 2
Sex: female 10 (36) 24 (77) 6 (40) 1 (50)
Age: median (IQR; min–max) years 53 (43–59; 29–64) 53 (32–61; 18–71) 46 (40–55; 29–64) 43 (36–49; 30–55)
Role         
  Clinician only 0 1 (3) 0 0
  Researcher/scientist only 5 (18) 0 3 (20) 0
  Clinician and researcher 23 (82) 0 12 (80) 0
  Neither clinician nor researcher/scientist 0 28 (97) 0 2 (100)
Tendinopathy cases per month   NA   NA
  None 5 (18)   3 (20)   
  At least 4 1 (4)   1 (6.7)   
  Between 5 and 10 2 (7)   2 (13.3)   
  Between 11 and 15 7 (25)   6 (40)   
  More than 16 13 (46)   3 (20)   
Years managing tendon problems /27 NA   NA
  None 0   1 (6.7)   
  At least 4 0   0   
  Between 5 and 10 2 (4)   3 (20)   
  Between 11 and 15 6 (22)   3 (20)   
  More than 16 19 (70)   8 (53.3)   
Highest academic qualification /26       
  Undergraduate diploma/certificate 0 5 (16) 0 0
  Bachelor 0 14 (45) 0 1 (50)
  Master 1 (4) 4 (13) 0 1 (50)
  PhD 23 (88) 5 (16) 13 (86.7) 0
  Clinical doctorate 2 (8) 0 1 (6.7) 0
  Other 0 3 (10) 1 (6.7) 0
Healthcare profession (some cited more than one)   ˆ     
  Physiotherapy 13 (40.6)   9 (56)   
  Sports and exercise medicine physician 8 (28.6)   3 (18.8)   
  Orthopaedic surgery 4 (12.5)   0 (0)   
  Rheumatology 3 (9.4)   1 (6.3)   
  Radiology 1 (3.1)   1 (6.3)   
  Human movement science 1 (3.1)   1 (6.3)   
  Epidemiology 1 (3.1)   1 (6.3)   
  Surgery 1 (3.1)   0 (0)   
Currently have tendon problem 8 (29) 26 (84) 4 (26.7) 2 (100)
History of tendon problem 19 (68) 21 (68) 10 (66.7) 1 (50)
Country where work         
  Australia 8 (28.6) 31 (100) 5 (33.3)   
  UK 5 (17.9)   1 (6.7)   
  The Netherlands 5 (17.9)   4 (26.7) 2 (100)
  Canada 2 (7.1)   1 (6.7)   
  USA 2 (7.1)   1 (6.7)   
  Denmark 2 (7.1)   1 (6.7)   
  Qatar 1 (3.6)   1 (6.7)   
  Sweden 1 (3.6)   0   
  Hong Kong 1 (3.6)   1 (6.7)   
  Norway 1 (3.6)   0   
Unless otherwise stated, data are N (%). ˆ2 (6.5) physiotherapists, 1 (3.2) nurse midwife, 1 (3.2) social worker, 1 (3.2) athlete.
NA, not applicable.
middle- distance runner with Achilles tendinopathy, both from 
Groningen, participated during the ISTS consensus meeting.
domains
Stage 1 resulted in 24 candidate domains (table 2), which formed 
the basis of the questions in the Delphi process. In addition 
to these 24 candidate domains, we asked survey participants 
to nominate any potential (candidate) tendon health- related 
domains they would remove, add or combine/amalgamate. We 
collated responses from the survey and sent them in a report 
out to attendees 10 days before the ISTS consensus meeting in 
Groningen (online supplementary appendix C).
From the HCP online survey, three candidate domains reached 
the predetermined ≥70% agree (or disagree) criterion. Pain on 
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Table 2 Domains considered in the meeting in response to the question ‘Is the ‘candidate domain (item)’ important enough to be included in a 
core domain set for tendinopathy?’
domain description/definition (example outcome)
Consensus 
meeting %
survey (hCP; 
P) %
some typical consensus meeting discussion 
points
Core domains (candidate domains (items) agreed ≥70% agree)
Participant/patient rating overall 
condition
A single assessment numerical evaluation (eg, rate your 
tendon status where 100% is no problems and 0% 
worst case scenario, global rating of change (how are 
you now compared with prior treatment),18–20 patient 
acceptable symptom status (Is your current symptom 
level acceptable?)).
100 61, 91 Considered to be the most patient- centred candidate 
domain.
Participation A patient rating of the level of participation/
engagement across areas of their life. (eg, ratings of 
level of sport and time to return to sport).21
94 * This resulted from the discussion on the three 
candidate domains considered in the survey and 
at the meeting, which were overall, sport and 
work participation. With the exception of the sport 
participation domain where the patients agreed it 
ought to be a core domain, this candidate domain 
did not reach agreement in the survey. Comments 
in the survey suggested amalgamation, which was 
supported at the meeting.
  Overall (eg, time to return to work, level of work 
(strenuousness)).
* 25, 65
  Sport participation * 57, 74
  Work participation * 46, 65
Pain on loading/activity Participant/patient reported intensity of pain on 
performing a task/activity that loads the tendon. 
(eg, VAS or NRS for pain intensity when the patient 
performs a tendon- specific pain- provocative task).22–24
† 93, 97 This was strongly agreed at the survey by both 
patients and HCP. Note that there were no 
disagreements. Tendon- specific loading tests would 
need to be determined (eg, pain on gripping an 
object by a patient with lateral elbow tendinopathy).
Function Participant/patient rated level of function (and not 
referring to the intensity of their pain; eg, Patient 
Specific Function Scale on a VAS or NRS).19
88 68, 87 Discussion centred around possible interdependence 
with Disability, which was resolved by considering 
this candidate domain as 'how much can the patient 
do' as opposed to the level of disability due to the 
pain.
Psychological factors Psychology (eg, pain self efficacy, pain 
catastrophisation, kinesiophobia, anxiety or depression 
scales).19
88 36, 77 There was some concern regarding interdependence 
with Quality of Life (QoL), both at the meeting and 
HCP survey. It was agreed that psychology was 
sufficiently important and broader than covered in 
QoL.
Physical function capacity Quantitative measures of physical tasks performed in 
clinic (eg, number of hops, timed stair walk, number of 
single limb squats, including dynamometry (strength) 
and wearable technology).19 25 26
88 57, 68 Some discussion about the differences between this 
and ‘function’, but resolved as this is a quantitative 
measure of the physical capacity (eg, number of 
repetitions of or time to do a task, muscle force/
torque) and not a patient rating of their function (eg, 
measured with a patient- specific function scale).
  Muscle capacity or ‘strength’ as it was considered in 
the survey and meeting.
* 36, 91 Muscle capacity of strength was merged under 
physical function capacity as it was considered a 
physical function measure and there was a high 
patient agreement at survey. It was rejected as a 
separate domain at the meeting (12.5% agree)
Disability Composite scores of a mix of patient- rated pain and 
disability due to the pain, usually relating to tendon- 
specific activities/tasks (eg, VISA scales,19 20 23 24 
patient- rated tennis elbow evaluation,27 disability of 
the arm, shoulder and hand).
† 86, 69 This was agreed at the survey stage and not 
discussed at the meeting.
QoL The general well being of the individual (specific QoL 
questionnaires such as European QoL -5 Dimension 
(EQ- 5D), Australian QoL (AQoL), 36- item Short Form 
survey (SF-36).19 20 27
75 57, 91 There was concern that there is no tendon- specific 
QoL measure, but that the overall well being of the 
individual was important to include as a domain.
Pain over a specified time Participant reported pain intensity over a period of time 
(morning, night, 24 hours, a week; eg, VAS, NRS).27–29
75 32, 69 The initial candidate domain was pain over 24 hours, 
but also referred to a period of time. After discussion, 
it was agreed that it was the 'timeframe' being 
specified that provided more utility (eg, for some 
tendons morning pain, others night).
Continued
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domain description/definition (example outcome)
Consensus 
meeting %
survey (hCP; 
P) %
some typical consensus meeting discussion 
points
  Candidate domains (items) not reaching ≥70% agree
 
 
Physical activity Overall physical activity levels (eg, self- report of 
physical activity levels, wearable sensor technology).
69 54, 81 Discussion centred around possible interdependence 
and overlap with other domains. Along with this 
being less specific to tendinopathy compared with 
what some of the other domains might be, it did 
not reach agreement. The 69% agreement could be 
viewed as indicating the overlap concern, but that 
this domain was one requiring further consideration.
Structure Tendon tissue characteristics (eg, MRI, US, biopsy). 69 43, 34 An extended discussion was had on this candidate 
domain, with some of the issues being: relationship 
to symptoms, diagnostic utility, technological, and 
availability of imaging modalities). It was decided to 
convene a group specific to imaging to deal with this 
candidate domain.
Medication use Medicines used (eg, patient report or record of type 
and dose).
63 57, 74 The direct relevance of medication use to 
tendinopathy was a feature of the discussion. It was 
also considered that it would be captured under 
other reporting guidelines for clinical trials.
Adverse effects/events Unwanted unintended effects of treatments (eg, patient 
report or medical record).
56 50, 58 Uncertainty about it being specific to tendinopathy, 
how to define it (eg, pain after exercise), and how to 
measure it. Discussion also considered that adverse 
effects are usually reported under harms as per the 
CONSORT guidelines.
Economic impact: costs Financial impost of the condition and its management 
(eg, patient report or medical record).
40 29, 55 There was an extended discussion, largely around 
relevancy, societal impact (funding for healthcare 
and associated research), and how to measure it.
  Not core domains (≥70% disagree)
Pain elicited with clinician applied 
stress/examination
Rating of pain when a clinician does an examination of 
the patient (eg, VAS or NRS for pain intensity).
21 18, 61 Considered more to be for diagnosis and selection 
into studies.
Clinical examination findings Clinician report of examination findings (eg, usually a 
composite score of a number of clinical examination 
tests).
13 29, 75 Considered important in a clinical examination, but 
the composite nature was not meaningful as an 
outcome.
Palpation Manual pressure elicited/evoked pain over the tendon 
(eg, VAS, NRS).
13 39, 68 Considered not to be related to resolution and 
difficult for some tendons (eg, Shoulder vs Achilles).
Range of motion Range of motion (eg, goniometer, inclinometer). † 11, 84 75% disagree HCP survey and not voted at the 
meeting.
Drop out or discontinue treatment Ceasing a treatment (eg, patient or clinical record). 6 46, 61 While considered important to be reported in clinical 
trials, it was not a key domain. Reiteration that 
candidate domains like this should still be reported 
as per other guidelines of reporting.
Sensory modality specific pain Pain thresholds/tolerance to sensory stimulation (eg, 
quantitative sensory testing).
6 11, 42 Considered likely useful in subgrouping studies but 
not as an outcome for trials.
Pain without further specification Patient asked about their pain without reference to 
activity or timeframe (eg, VAS, NRS).
0 25, 63 Covered better in pain on loading and over a 
specified timeframe.
Note that the citations placed in the definition column are only examples of some authors reporting of indicative outcome measures and they are not to be read as endorsing 
either the outcomes or their use.
*Amalgamated items (candidate domains).
†Met the agreed criterion prior to meeting and thus not discussed at the meeting.
CONSORT, Consolidated Standards of Reporting Trials; HCP, Health Care Professionals; MRI, Magnetic Resonance Imaging; NRS, Numeric Rating Scale; QoL, Quality of Life; US, 
Ultrasound; VAS, Visual Analogue Scale; VISA, Victorian Institute of Sports Assessment.
Table 2 Continued
activity/loading and disability were voted as core domains and 
range of motion voted as not appropriate to be a core domain.
From the patient online survey, 11 candidate domains were 
voted as core domains (see online supplementary appendix C). 
No candidate domains met the ≥70% disagree criterion. Pain on 
activity/loading was the only candidate domain that was voted 
into the core domain by both patients and HCP.
At the ISTS consensus meeting, attendees moved seven candi-
date domains from an ‘unsure’ status to ≥70% agreement which 
elevated them to core domain status (table 2): these seven were: 
patient rating of condition, participation, function, psychological 
factors, physical function capacity, quality of life and pain over a 
specified time. As explained in table 2, function is patient rated 
(eg, as might be captured on a patient- specific function scale) 
whereas physical function capacity is a quantitative measure of 
function (eg, strength measured on dynamometer).
Attendees at the ISTS consensus meeting amalgamated five 
separate candidate domains from the survey into two core 
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Table 3 Brief overview of the findings (at the 70% core/not- core 
threshold)*
Voted as ‘a core domain when reporting 
patient outcomes in tendinopathy’ (≥70% 
agreement)
Voted as ‘not a core domain 
when reporting patient 
outcomes in tendinopathy’ 
(≥70% agreement)
Patient rating of condition Range of motion
Pain on activity/loading Pain on clinician examination
Participation (daily activities, work, sport)† Clinical examination findings
Function Palpation
Psychological factors Drop out
Disability Sensory modality specific pain
Physical function capacity (including strength)† Pain without further specification
Quality of life
Pain over a specified timeframe
*See table 2 for details (and for those candidate domains remaining undecided).
†Candidate domains amalgamated to one domain.
domains. The core domain of participation was introduced as 
an amalgamation of candidate domains of participation in sport, 
work and global participation. The core domain of physical 
function capacity was the amalgamation of physical function 
and strength.
Seven candidate domains reached the ≥70% voting threshold 
for agreement that they should not serve as core domains 
(table 2). Four of these involved clinician examination (ie, pain 
on clinician examination, examination findings, palpation, range 
of motion). Pain without further specification (ie, context) was 
deemed to be more precisely covered under the two domains, 
pain on loading/activity and pain over specified time. Drop outs 
and sensory modality specific pain were the others.
We were undecided on the other five candidate domains: 
physical activity, structure, medication use, adverse effects and 
economic impact.
An infographic that conveys the salient design features and 
results has been developed to assist in the implementation 
of the ICON 9 core domains (online supplementary file 4). 
dIsCussIon
Brief overview of the findings (at the 70% core/not- core 
threshold) is presented in table 3.
What might the nine core domains mean?
The nine core domains reflect how HCPs and patients under-
stand the nature of tendinopathy. They encompass both physical 
(eg, pain on loading, aspects of participation, function, physical 
function capacity, disability), psychosocial (eg, psychological 
factors, aspects of participation and pain ratings) and overall 
status/life impact (eg, patient rating of condition and quality of 
life).
There was a 100% agreement that pain could not be measured 
without reference to context (eg, either to an activity or over 
a defined period). That is, ratings of pain intensity should be 
made on the basis of some specific activity, loading or time point/
timeframe.
Six of the seven core domains decided at the ISTS consensus 
meeting (two having reached the 70% agree threshold prior at 
the survey stage) had reached the core domain inclusion crite-
rion in the online survey of patients. The six core domains of 
patient rating of condition, participation, function, physical 
function capacity, psychological factors and quality of life were 
agreed- upon by both HCP and patients. This adds weight to our 
belief that these domains are meaningful health- related domains 
for tendinopathy. When HCP and patients agree on domains, 
OMERACT refers to them as ‘inner’ core domains.9 We recom-
mend that outcome measures used in research and clinical prac-
tice align with each of these core domains, but does not prevent 
the inclusion of other outcome measures.
What comes next? We will need to define core outcome 
measures
The next stage will be for HCP with relevant expertise and 
patients with tendinopathies to establish the core outcome 
measures (ie, core outcome sets) that align with each of the core 
domains for the different regional tendinopathies.9 Many of the 
domains specifically relate to tasks, activities, sports/recreational 
pursuits and work/occupations that load a specific tendon. For 
example, specific activities, tasks and sport/occupations that are 
associated with Achilles tendinopathy (eg, distance running) 
are likely very different to those associated with patellar tendi-
nopathy (eg, jumping sports) or lateral elbow tendinopathy (eg, 
racquet sports, golf, manual labour). Now that we have deter-
mined nine core domains for tendinopathy the ICON group 
resolved to establish anatomic site- specific working groups to 
establish core outcome sets for each of the common tendinop-
athies. An example of a protocol for developing core outcomes 
for Achilles tendinopathy can be seen in the Core Outcome 
Measures in Effectiveness Trials (COMET) database (http://
www. comet- initiative. org/ studies/ details/ 1323).
Structure morphology of tendon (as captured by tendon imaging 
modalities)
The concept of tendon structure did not reach the 70% threshold 
to be considered a core domain. In the survey, 34% of HCPs and 
43% of patients voted that structure should be a domain. After 
much discussion at the ISTS consensus meeting, 69% of partici-
pants voted that structure should be a core domain.
The main reason for resistance to structure being a core domain 
related to imaging. Imaging appearance of tendon has a variable 
and at present unclear relationship with symptoms and it has low 
diagnostic utility over clinical assessment in many settings.14 As 
imaging is not always available that would limit its usefulness as 
a core domain.15 The ICON group formed a working group to 
further explore imaging and the structure domain and we plan 
to revisit the topic at the 2020 ISTS meeting in Valencia, Spain.
Alignment with OMERACT core areas
Eight of the nine core domains reflect the life impact core area 
of OMERACT.15 Apart from physical function capacity, no core 
domains aligned with the OMERACT core areas of (1) patho-
physiological manifestations (eg, structure 69%, palpation 13%, 
range of motion 11%), (2) death (eg, drop out 6% agreement, 
adverse effects approximately 60% agreement) or (3) resource 
use (economic impact 40% agreement, medication use circa 60% 
agreement).
An interesting outcome of the ICON core domain process was 
the poor representation of the OMERACT core area of patho-
physiological manifestations. The conventional/prevailing view 
of tendinopathy is that it is a local tissue pathology, which is 
plausibly/intuitively aligned with structure and function domains 
of the ICF, represented under pathophysiological manifesta-
tions concept/area in the OMERACT schema. A clear signal 
of the current conceptualisation of tendinopathy being more 
than a local tendon condition is apparent from the nine core 
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Feature box
ICon group recommends that:
 ► Clinical trials should include a measure for each of the nine 
core domains at a minimum, so that future meta- analyses 
will be able to better estimate treatment effects.
 ► These core domains should be used alongside clinical trial 
reporting guidelines (e.g.,) when conducting and reporting 
clinical trials.
 ► In future, core outcome sets need to be established for 
each of the common tendinopathies (eg, Achilles tendon, 
lateral elbow tendon), using these nine core domains as the 
guide (and an update reported at the future ISTS). Outcome 
measures should be valid, responsive and feasible as per the 
OMERACT guidelines.
 ► A special interest group of knowledgeable specialist 
radiologists and clinician scientists should discuss imaging 
further with a view to resolving whether tendon structure 
ought to be included as a core domain.
 ► The agreed core domains should not prevent the use of other 
outcomes in trials or clinical practice. The nine core domains 
represent the minimal reporting requirement.
tendinopathy domains not including many of the potential 
candidate domains that belong to the pathophysiological mani-
festations area in OMERACT.
There was agreement at the meeting that candidate domains such 
as adverse events and medication (other treatments) use would be 
covered generically for all trials as per reporting guidelines (eg, 
Consolidated Standards of Reporting Trials (CONSORT)).16 In 
summary, the core outcome domains for tendinopathy are predom-
inantly of the OMERACT core area of life impact.
Candidate domains about which the group members disagreed were 
core domains
There was a prevailing view at the ISTS consensus meeting that 
candidate domains that were voted not to be core domains (≥70% 
disagree) may still retain use in the clinic. For example, tendon 
palpation and range of motion, while not core domains, will still 
be part of a clinical examination. Interestingly, the patient’s survey 
had these candidate domains as core (≥70% agree).
Another example was that the measurement of sensory 
modality- specific pain with quantitative sensory testing was 
deemed to be of likely importance in stratification of groups 
of individuals with tendinopathy on the basis of prognosis and 
possibly predicting treatment outcomes,17 but not as a measure 
of a health- related nature and thus outcome.
strengths
A strength of the process we undertook in deciding these core 
domains for tendinopathy was that it involved individuals of 
both sexes, experienced in either treating/researching tendinop-
athy from a range of professions and countries. We also surveyed 
patients who had been diagnosed with tendinopathy by a HCP 
and involved two local patients in the ISTS consensus meeting. 
That along with many of the HCP having also experienced tend-
inopathy provides a level of assurance that the core domains 
for tendinopathy are meaningful entities representing health- 
related domains of patients with tendinopathy. The research 
was conducted independent of any funding source (eg, pharma, 
healthcare profession associations, sponsors).
limitations
We were only able to have two local patients at the face- to- face 
ISTS consensus meeting and the online survey of patients was 
only conducted in Australia. This imposes a caveat on inter-
preting the patient survey responses, especially on the candidate 
domains of physical activity levels, medication use, clinical exam-
ination findings and range of motion (table 2). Notwithstanding 
this, the patient views at the consensus meeting appeared to align 
with the online survey.
The discussion on the structure (imaging largely) candidate 
domain raised the issue that we only engaged a single radiol-
ogist in the Delphi study. This was slightly offset by the three 
sports medicine physicians and three physiotherapists who all 
had published imaging studies in collaboration with radiologists. 
The meeting decided that further work on imaging (structure) 
was required and should include greater involvement of muscu-
loskeletal radiologists who are expert in tendinopathies.
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